DaVita and Archer Daniels Midland Gain Over 30% YTD Stock Performance
What happened
DaVita and Archer Daniels Midland both achieved year-to-date gains of over 30% in their stock prices as of September 21, 2026. DaVita's growth is supported by improved reimbursement rates and cost discipline, with analysts projecting further earnings growth. Meanwhile, Archer Daniels Midland raised its guidance despite operating amid volatile global trade conditions.
From yahoo.com
Why it matters
The performance highlights the operational strengths of companies outside the dominant AI sector. For DaVita, the growth is tied to its specialized kidney dialysis business. For Archer Daniels Midland, the performance reflects its ability to navigate global commodity market risks.
From yahoo.com
Who's involved
- DaVitaRenal dialysis company whose stock performance was noted.
- Archer Daniels MidlandGlobal food processing and commodities trading corporation whose stock performance was noted.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Berkshire HathawaySpeculative
Berkshire Hathaway could see the value of its substantial equity stake in DaVita increase due to the company's strong performance.
Keep exploring
The entities involved
-
DaVita
renal dialysis center chain based in the United States
Nothing else this week.
-
Archer Daniels Midland
American global food processing and commodities trading corporation
- Archer Daniels Midland is expanding its operations in Nebraska, operating a corn-processing complex and partnering with Tallgrass, LLC.
- Archer Daniels Midland is utilizing its facilities in Decatur, Illinois, and Columbus, Nebraska, for carbon capture and storage, with Puro.earth certifying the removal credits.